About

Orano USA is a leading technology and services provider for advanced reactors, uranium/conversion/enrichment services, used nuclear fuel management, decommissioning nuclear sites, and site cleanup and closure for the U.S. commercial and federal markets. Orano Med is developing targeted alpha therapy to fight cancer.

With more than 60 years operating in the U.S., Orano USA is a leading technology and services provider in commercial and federal markets for advanced reactors, uranium conversion and enrichment, nuclear fuel transport, used nuclear fuel storage and transport, site cleanup and remediation, and useful radioactive isotopes. Orano is developing the Project IKE uranium enrichment facility in Oak Ridge, TN, as a significant American nuclear fuel supply. In nuclear medicine, Orano Med is developing a new generation of targeted therapies against cancer using the unique properties of lead-212 (212Pb). Follow us on LinkedIn.